EUVIMEDEUVIMED entdecken
Crossref

CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin

J. Tate Thigpen

Clinical Ovarian Cancer · 2011

DOI: 10.1016/j.cloc.2012.02.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von J. Tate Thigpen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Thigpen, J. T. (2011). CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.017

Vancouver

Thigpen JT. CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.017

BibTeX
@article{Thigpen2011,
  author = {Thigpen, J. Tate},
  title = {CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin},
  journal = {Clinical Ovarian Cancer},
  year = {2011},
  doi = {10.1016/j.cloc.2012.02.017}
}
Kostenlos starten →